118 related articles for article (PubMed ID: 28245374)
1. [Expression of MCL-1 in Primary Acute Myeloid Leukemia Cells and Its Clinical Significance].
Chen P; Jin Q; Jiang X; You PD; Yuan Q; Huang HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):50-54. PubMed ID: 28245374
[TBL] [Abstract][Full Text] [Related]
2. [Expression of HIF-1α in primary acute myeloid leukemia cells and its relationship with prognosis].
Chen P; Jiang X; Huang HF; Yuan Q; Wu JY; Guo YF; Chen YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):19-23. PubMed ID: 25687039
[TBL] [Abstract][Full Text] [Related]
3. [Expression of survivin in patients with acute myeloid leukemia].
Sun WX; Zhang PH; Fang LH; Tian Z; Tang KJ; Rao Q; Wang M; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1099-104. PubMed ID: 24156414
[TBL] [Abstract][Full Text] [Related]
4. [Expression of CD25 in Acute Myeloid Leukemia Is An Adverse Prognostic Factor Independent of the Chromosome Karyotype].
Liu YF; Dong L; Wang C; Sun H; Zhang QT; Wang M; Li T; Xu Y; Ma J; Xie XS; Sun L; Wan DM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):332-5. PubMed ID: 27150987
[TBL] [Abstract][Full Text] [Related]
5. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
Zhang TJ; Guo H; Zhou JD; Li XX; Zhang W; Ma JC; Wen XM; Yao XY; Lin J; Qian J
Pathol Res Pract; 2018 Jan; 214(1):169-173. PubMed ID: 29254789
[TBL] [Abstract][Full Text] [Related]
7. [Expression and Clinical Significance of CAS in Acute Myeloid Leukemia Patients].
Guo HR; Wang X; Zhang H; Guan KP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):744-749. PubMed ID: 35680799
[TBL] [Abstract][Full Text] [Related]
8. MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
Wang CC; Liu HE; Lee YL; Huang YW; Chen YJ; Liou JP; Huang HM
Tumour Biol; 2016 May; 37(5):6065-72. PubMed ID: 26608370
[TBL] [Abstract][Full Text] [Related]
9. [PRPS1 Expression in Children with Acute Leukemia and Its Clinical Significance].
Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
[TBL] [Abstract][Full Text] [Related]
10. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
11. c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia.
Liu S; Qiao X; Wu S; Gai Y; Su Y; Edwards H; Wang Y; Lin H; Taub JW; Wang G; Ge Y
Apoptosis; 2022 Dec; 27(11-12):913-928. PubMed ID: 35943677
[TBL] [Abstract][Full Text] [Related]
12. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.
Zhao J; Niu X; Li X; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Ge Y
Oncotarget; 2016 Jun; 7(23):34785-99. PubMed ID: 27166183
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of PD-L1 Expression with the Clinical Features and Prognosis of Patients with Primary Acute Leukemia].
Ma H; Li N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1034-8. PubMed ID: 27531770
[TBL] [Abstract][Full Text] [Related]
15. [Expression and Clinical Significance of CC-chemokine Receptor 7 in Adult Acute Leukemia].
Li SQ; Guo R; Gan SL; Jiang ZX; Yue BH; Ma J; Liu YF; Xie XS; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):311-5. PubMed ID: 27150983
[TBL] [Abstract][Full Text] [Related]
16. [Expression of antiapoptotic gene aven in de novo acute myeloid leukemia patients and its clinical significance].
Geng SX; DU X; Weng JY; Zhong LY; Guo R; Lu ZS; Chen ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1424-8. PubMed ID: 20030919
[TBL] [Abstract][Full Text] [Related]
17. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
18. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
[TBL] [Abstract][Full Text] [Related]
19. The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations.
Tian T; Yu S; Liu L; Xue F; Yuan C; Wang M; Ji C; Ma D
PLoS One; 2015; 10(7):e0131761. PubMed ID: 26134277
[TBL] [Abstract][Full Text] [Related]
20. [Expression and Clinical Significance of LcnRNA XLOC_109948 in Patients with Acute Myeloid Leukemia].
Zhou JY; Wang YM; Peng QY; Hui HL; Yin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1539-1544. PubMed ID: 33067951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
